Importantly, a number of these, including ivermectin, which is of current interest with respect to SARS-CoV-2, have been shown to limit viral infection by preventing the host IMPα recognition/nuclear localization of viral proteins in infected cells [19,20,22,23,24,25,26,27,28,29,30]. The gene discussed is IMPA1; the disease is viral infectious disease.